Xavier Paoletti

11PUBLICATIONS
107CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsChemotherapyPredictive and prognostic markersPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 27, 2026
Phase I/II Study of the PARP Inhibitor Olaparib and Irinotecan in Children and Young Adults with Recurrent/Refractory Malignancies: Arm D of the AcSé-ESMART Trial.

Susanne A Gatz, Pablo Berlanga, Gwénaël Le Teuff

|May 14, 2024
Evolution of the Innovative Therapies for Children With Cancer Consortium Trial Portfolio for Drug Development for Children With Cancer.

Francisco Bautista, Jaime Verdú-Amorós, Birgit Geoerger

|Dec 05, 2023
Phase I/II Study of the WEE1 Inhibitor Adavosertib (AZD1775) in Combination with Carboplatin in Children with Advanced Malignancies: Arm C of the AcSé-ESMART Trial.

Susanne A Gatz, Anne C Harttrampf, Caroline Brard

|Jul 19, 2023
Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma.

Matthieu Faron, Maurice Cheugoua-Zanetsie, Jayne Tierney

|Apr 04, 2023
Combination Early-Phase Trials of Anticancer Agents in Children and Adolescents.

Lucas Moreno, Steven G DuBois, Julia Glade Bender

|Aug 04, 2021
Phase I or II Study of Ribociclib in Combination With Topotecan-Temozolomide or Everolimus in Children With Advanced Malignancies: Arms A and B of the AcSé-ESMART Trial.

Francisco Bautista, Xavier Paoletti, Jonathan Rubino

Pageof 2

Frequent Collaborators

5 joint publications

Birgit Geoerger

4 joint publications

Nicolas Andre

4 joint publications

Gilles Vassal

3 joint publications

Susanne A Gatz